United Therapeutics UTHR Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from United Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is United Therapeutics's earnings yield?
- United Therapeutics (UTHR) reported earnings yield of 5% in Q1 2026.
- How has United Therapeutics's earnings yield changed year-over-year?
- United Therapeutics's earnings yield decreased by 43.4% year-over-year, from 8.7% to 5%.
- What is the long-term trend for United Therapeutics's earnings yield?
- Over 4 years (2021 to 2025), United Therapeutics's earnings yield has grown at a 9.6% compound annual growth rate (CAGR), from 21.7% to 31.3%.
- What does earnings yield mean?
- The company's annual profit as a percentage of its market price — the flip side of the P/E.
- How do you interpret earnings yield?
- Higher means more earnings per dollar invested. Easy to compare directly against bond yields to judge the relative attractiveness of equity.
- How does earnings yield compare across companies?
- Comparable across profitable companies and against fixed-income yields; undefined when earnings are negative.